All In Biotech

Drug Trial Radar · NCT03138733

Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia

A Randomized, Double-blind, Multi-center Study to Establish the Efficacy and Safety of Ceftobiprole Medocaril Compared to Daptomycin in the Treatment of Staphylococcus Aureus Bacteremia, Including Infective Endocarditis

Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 390 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

390

Actual

Start

Aug 26, 2018

Primary completion

Mar 11, 2022

Study completion Mar 11, 2022

Sponsor

Lead sponsor
Basilea PharmaceuticaIndustry
Sponsor type
Industry
Collaborators
Biomedical Advanced Research and Development Authority
First posted
May 3, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to compare the efficacy and safety of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated Staphylococcus aureus bacteremia (SAB).

Conditions

  • Staphylococcus Aureus Bacteremia

Interventions

  • Ceftobiprole medocarilDrug

    Ceftobiprole 500 mg (as 667 mg ceftobiprole medocaril) as a 2 h infusion

  • DaptomycinDrug

    Daptomycin 6 mg/kg (up to 10 mg/kg based on institutional standards) as a 0.5 h infusion, with or without aztreonam

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients With or Without Overall Success at the Post-treatment Evaluation (PTE) VisitTime frame: PTE visit on Day 70 (± 5 days) post-randomization

Locations

60 sites in 17 countries. Site status is shown where the registry gives one.

  • eStudy Site - Chula Vista - PPDS

    Chula Vista, California

  • Triple O Medical Services Inc

    West Palm Beach, Florida

  • Mercury Street Medical Group

    Butte, Montana

  • eStudy Site - Las Vegas - PPDS

    Las Vegas, Nevada

  • Remington Davis Inc.

    Columbus, Ohio

  • Central Hospital de San Isidro Melchor Posse

    Buenos Aires, Argentina

  • Medical Institute Platense SA

    La Plata, Argentina

  • British Sanatorium SA

    Rosario, Argentina

  • University Multiprofile Hospital for Active Treatment "Eurohospital Plovdiv", Plovdiv, Intensive Care Clinic

    Plovdiv, Bulgaria

  • University Multiprofile Hospital for Active Treatment 'Kanev', Ruse, Department of General, Purulent-Septic, Pediatric and One Day Surgery

    Rousse, Bulgaria

  • Multiprofile Hospital for Active Treatment "Dr. Ivan Seliminski", Sliven, Anesthesiology and Intensive Care Department

    Sliven, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine "N.I. Pirogov", Sofia, Clinic of Purulent-Septic Surgery

    Sofia, Bulgaria

  • De La Costa Clinic Ltd.

    Barranquilla, Colombia

  • JSC Rustavi Central Hospital

    Rustavi, Georgia

  • LTD High Technology Medical Center University Clinic

    Tbilisi, Georgia

  • LTD Academician G. Chapidze Emergency Cardiology Center

    Tbilisi, Georgia

  • LTD Institute of Clinical Cardiology

    Tbilisi, Georgia

  • LTD Academician Vakhtang Bochorishvili Clinic

    Tbilisi, Georgia

  • LTD Central University Clinic After Academic N. Kipshidze

    Tbilisi, Georgia

  • LTD N 5 Clinikal Hospital

    Tbilisi, Georgia

  • University Hospital Regensburg, Department of Infectious Diseases

    Regensburg, Germany

  • "LAIKO" General Hospital, 1st Department of Internal Medicine

    Athens, Greece

  • Bnai Zion Medical Center

    Haifa, Israel

  • The Baruch Padeh Medical Center

    Poria Illit, Israel

  • Chaim Sheba Medical Center

    Ramat Gan, Israel

  • Sieff Medical Center

    Safed, Israel

  • Sourasky Medical Center

    Tel Aviv, Israel

  • IRCCS-University Hospital San Martino-IST, Infectious Diseases Division

    Genoa, Italy

  • University of Milan-Bicocca- S.Gerardo Hospital

    Monza, Italy

  • Giuliano Isontina University Health Authority

    Trieste, Italy

  • Central Friuli University Healthcare Company

    Udine, Italy

  • Fray Antonio Alcalde Guadalajara Civil Hospital

    Guadalajara, Mexico

  • Dr. Jose Eleuterio Gonzalez Monterrey University Hospital

    Monterrey, Mexico

  • INDICASAT SMO / Santo Tomas Hospital, Investigation Department

    Panama City, Panama

  • St. Joseph Belgorod Regional Clinical Hospital

    Belgorod, Russia

  • Vinogradov Moscow Municipal Hospital, Department of Surgery #14

    Moscow, Russia

  • N.I. Pirogov City Clinical Hospital #1

    Moscow, Russia

  • Federal State Budget Institution "Central Clinical Hospital with Polyclinic" under the Presidential Executive Office of Russian Federation

    Moscow, Russia

  • L.A. Vorokhobov City Clinical Hospital #67

    Moscow, Russia

  • City Hospital #33

    Nizhny Novgorod, Russia

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.